Previous Page  15 / 15
Information
Show Menu
Previous Page 15 / 15
Page Background

Page 37

Notes:

conferenceseries

.com

Volume 6

Journal of Infectious Diseases & Therapy-Open Access

Infectious Diseases Congress 2018

November 15-16, 2018

November 15-16, 2018 Istanbul, Turkey

6

th

Annual Conference on

Parasitology & Infectious Diseases

Mesenchymal stem cell as a cure for brain damage induced by chronic

Toxocara canis

infection

in an

experimental mouse model

Fatma Hamed Shalan

1

, Ayman Abd El-Moenem Elbadry

2

, Amera Fathy Afifi

1

, Engy Victor Nassief Beshay

1

, Samar Ahmed El-Refai

1

, Hala Gabr Metwaly

3

,

Eman Ahmedy

4

, Eman Abd El-Fattah Badr

5

, Dalia Refaat Al-Sharaky

6

and Gehan Salah Sadek

1

1

Parasitology Department, Faculty of Medicine, Menoufia University, Egypt

2

Parasitology Department, Faculty of Medicine, Cairo University, Egypt

3

Clinical Pathology Department, Faculty of Medicine, Cairo University, Egypt

4

Clinical Pathology Department, Faculty of Medicine, Menoufia University, Egypt

5

Biochemistry Department, Faculty of Medicine, Menoufia University, Egypt

6

Pathology Department, Faculty of Medicine, Menoufia University, Egypt

N

eurotoxocariasis is a serious condition linked to the reduced cognitive function in children and some neurodegenerative

diseases. Unfortunately, the available drugs for its treatment are with variable results. Mesenchymal stem cells (MSCs)

have been used in experimental and clinical trials and it gave promising therapeutic results. Therefore, this study was designed

using forty T. canis-infected albino mice (1000 eggs/mouse, orally) and a control group (GI) of ten healthy mice. The infected

groups were GII: infected non-treated (control group), GIII: albendazole-treated (100 mg/kg/d once orally for 5 successive

days), GIV: MSCs-treated (3 x 10

6

MSCs in 0.1 mL of PBS via the tail vein) and GV: albendazole + MSCs-treated. Treatment

was commenced 6 weeks p.i. and the experiment was terminated four weeks after treatment. The brain tissue of each mouse

was subjected for histopathological, immunohistochemical studies (caspase-3, TGF-β), detection or

T. canis

DNA by real-time

PCR and gene expression the biomarkers of brain damage (S100B, GFAP) by RT-PCR. Moreover, homing of iron oxide-labelled

MSCs in brain tissues was assessed by Prussian blue stain. The brain tissues of GII showed numerous

T. canis

larvae, significant

congestion, thickening of arterioles, inflammatory infiltrate and gliosis associated with marked immunohistochemical

expression of TGF-β and caspase-3 as well as marked S100B and GFAP gene expression. Significant improvements of the

previous parameters and

T. canis

DNA were recorded in all the treated groups. However, the best results were obtained with

combined albendazole + MSCs therapy. Thus, MSCs could be considered in the treatment of chronic neurotoxocariasis.

Biography

Fatma shalan has completed her bachelor of medicine with excellent grade in 2006 from Faculty of Medicine, Menofia University. She has completed her

M.Sc

.

in Medical Parasitology in 2012. Her thesis was about the relationship between IL-6 and some parasitic infections in hepatic patients in Menofia governorate. This

abstract is representative of her M.D. thesis.

dr.fatma.shaalan@gmail.com

Fatma Hamed Shalan et al., J Infect Dis Ther 2018, Volume 6

DOI: 10.4172/2332-0877-C5-050